Tumor Immunotherapy
Psychodynamic Perspectives on Personality
What is Conservation Biology?
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
The Behavioral Perspective on Personality
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 10, 2026

BioMEMS and Cellular Biology: Perspectives and Applications
Published on: October 1, 2007
Xue-Tao Li1, Jin-Ji Yang2, Yi-Long Wu2
1Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou 510080, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China.
Combining immune checkpoint inhibitors with other therapies offers a promising strategy to improve non-small-cell lung cancer (NSCLC) treatment outcomes. This approach aims to overcome the limitations of monotherapy and enhance anti-tumor activity in more patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: